A deal to buy Irvine-based Micro Therapeutics Inc. for some $115 million is set to wrap up in early January, acquirer Ev3 Inc. said Thursday.
Ev3, a Plymouth, Minn.-based device maker that already owns 70% of Micro, said it expects to acquire the rest of the company’s shares on or about Jan. 6.
Micro makes devices to tackle blood vessel diseases.
The deal doesn’t require approval by minority Micro shareholders.
But the two companies, along with several of their officers and directors, were sued in October by Lascala Partners, a shareholder that alleged the deal undervalued Micro.
Ev3’s said in federal filings that it believes the suit is without merit.
